Neutral and Cationic Group 13 Phosphinimine and Phosphinimide Complexes

1999 ◽  
Vol 18 (20) ◽  
pp. 4197-4204 ◽  
Author(s):  
Christopher M. Ong ◽  
Peggy McKarns ◽  
Douglas W. Stephan
Keyword(s):  
Group 13 ◽  
Cationic Group

Cationic group 13 complexes

1998 ◽  
Vol 176 (1) ◽  
pp. 407-430 ◽  
Author(s):  
David A. Atwood
Keyword(s):  
Group 13 ◽  
Cationic Group

Neutral and Cationic Group 13 Alkyl and Hydride Complexes of a Phosphinimine−Amide Ligand

2004 ◽  
Vol 23 (8) ◽  
pp. 1819-1824 ◽  
Author(s):  
Jason D. Masuda ◽  
Denise M. Walsh ◽  
Pingrong Wei ◽  
Douglas W. Stephan
Keyword(s):  
Group 13 ◽  
Hydride Complexes ◽  
Cationic Group

scholarly journals An NHC‐stabilized H2GeBH2 precursor for the preparation of cationic group 13/14/15 hydride chains

2021 ◽  
Author(s):  
Matthias Ackermann ◽  
Michael Seidl ◽  
Fuwei Wen ◽  
Michael Ferguson ◽  
Alexey Timoshkin ◽  
...  
Keyword(s):  
Group 13 ◽  
Cationic Group

Cationic aluminum, gallium, and indium complexes in catalysis

2021 ◽  
Author(s):  
Hyuk-Joon Jung ◽  
Youngjung Cho ◽  
Diana Kim ◽  
Parisa Mehrkhodavandi
Keyword(s):  
Lewis Acid ◽  
Acid Catalysts ◽  
Lewis Acid Catalysts ◽  
Group 13 ◽  
Reaction Type ◽  
Indium Complexes ◽  
Cationic Group

The introduction of cationic charge allows cationic group 13 complexes to be excellent Lewis acid catalysts. Cationic aluminum, gallium, and indium complexes in catalysis are comprehensively reviewed based on the reaction type.

Unexpected alkane elimination from cationic group 13 dialkyls in a reaction with a macrocyclic polyamine

2017 ◽  
Vol 46 (3) ◽  
pp. 651-655 ◽  
Author(s):  
Debabrata Mukherjee ◽  
Thomas P. Spaniol ◽  
Jun Okuda
Keyword(s):  
Thermally Stable ◽  
Macrocyclic Polyamine ◽  
Group 13 ◽  
Cationic Group ◽  
Alkane Elimination

A macrocyclic polyamine 1,4,7-trimethyl-1,4,7,10-tetraazacyclododecane, (Me3TACD)H formed thermally stable adducts with MR3 (M = Al, In) but released RH from reactions with [MR2]+.

ChemInform Abstract: Cationic Group 13 Complexes

ChemInform ◽  
2010 ◽  
Vol 30 (12) ◽  
pp. no-no
Author(s):  
David A. Atwood
Keyword(s):  
Group 13 ◽  
Cationic Group

Special Interest Group 13 (Swallowing and Swallowing Disorders)

ASHA Leader ◽  
2012 ◽  
Vol 17 (5) ◽  
Author(s):  
Debra Suiter ◽  
Laurie Sterling ◽  
Lynne Brady Wagner
Keyword(s):  
Interest Group ◽  
Special Interest ◽  
Swallowing Disorders ◽  
Special Interest Group ◽  
Group 13

scholarly journals Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: a single-blind, randomized study

2008 ◽  
Vol 66 (2a) ◽  
pp. 216-220 ◽  
Author(s):  
Abouch Valenty Krymchantowski ◽  
Henrique Carneiro ◽  
Jackeline Barbosa ◽  
Carla Jevoux
Keyword(s):  
Acute Treatment ◽  
Rescue Medication ◽  
International Headache Society ◽  
Randomized Study ◽  
Group 13 ◽  
Lysine Clonixinate ◽  
Inflammatory Drugs ◽  
Rectal Indomethacin ◽  
Single Blind ◽  
Severe Migraine

BACKGROUND AND OBJECTIVE: Nonsteroidal anti-inflammatory drugs (NSAID) are effective to treat migraine attacks. Lysine clonixinate (LC) and dipyrone (metamizol) have been proven effective to treat acute migraine. The aim of this study was to evaluate the efficacy and tolerability of the intravenous formulations of LC and dipyrone in the treatment of severe migraine attacks. METHOD: Thirty patients (28 women, 2 men), aged 18 to 48 years with migraine according the International Headache Society (IHS) (2004) were studied. The patients were randomized into 2 groups when presenting to an emergency department with a severe migraine attack. The study was single-blind. Headache intensity, nausea, photophobia and side effects were evaluated at 0, 30, 60 and 90 minutes after the drug administration. Rectal indomethacin as rescue medication (RM) was available after 2 hours and its use compared between groups. RESULTS: All patients completed the study. At 30 minutes, 0% of the dipyrone group 13% of the LC group were pain free (p=0.46). At 60 and 90 minutes, 2 (13%) and 5 (33%) patients from the dipyrone group and 11 (73%) and 13 (86.7%) patients from the LC group were pain free (p<0.001). At 60 minutes, significantly more patients from the LC group were nausea-free (p<0.001). Regarding photophobia, there were no differences between groups at 60 minutes (p=0.11). The use of RM at 2 hours did not differ among groups (p=0.50). Pain in the site of the injection was reported by more patients of the LC group compared to the dipyrone group (p<0.0001). CONCLUSION: LC is significantly superior to dipyrone in treating severe migraine attacks. LC promotes significantly more burning at the site of the injection.

Sign in / Sign up

Export Citation Format

Share Document